# Pediatric Bipolar Depression

> **NCT00811473** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 193 (actual)

## Conditions studied

- Bipolar Depression

## Interventions

- **DRUG:** Quetiapine XR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00811473
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 193 (ACTUAL)
- **Last updated:** 2014-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00811473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00811473, "Pediatric Bipolar Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00811473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*